Search Results - Markus Luster

Refine Results
  1. 1
    Dosimetry and thyroid cancer: the individual dosage of radioiodine

    Dosimetry and thyroid cancer: the individual dosage of radioiodine by Michael Laßmann, Christoph Reiners, Markus Luster

    Published 2010
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Thyroid cancer in childhood: Management strategy, including dosimetry and long-term results

    Thyroid cancer in childhood: Management strategy, including dosimetry and long-term results by Markus Luster, Michael Laßmann, Lutz S. Freudenberg, Christoph Reiners

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases

    Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases by Frederik A. Verburg, Uwe Mäder, Markus Luster, Christoph Reiners

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Pediatric papillary thyroid cancer: current management challenges

    Pediatric papillary thyroid cancer: current management challenges by Frederik A. Verburg, Hanneke M. van Santen, Markus Luster

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma

    Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma by Heribert Hänscheid, Michael Laßmann, Markus Luster, Richard T. Kloos, Christoph Reiners

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Use of Recombinant Human Thyrotropin before Radioiodine Therapy in Patients with Advanced Differentiated Thyroid Carcinoma

    Use of Recombinant Human Thyrotropin before Radioiodine Therapy in Patients with Advanced Differentiated Thyroid Carcinoma by Markus Luster, Michael Laßmann, Heribert Haenscheid, U. Michalowski, C. Incerti, Christoph Reiners

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Non-Surgical and Non-Radioiodine Techniques for Ablation of Benign Thyroid Nodules: Consensus Statement and Recommendation

    Non-Surgical and Non-Radioiodine Techniques for Ablation of Benign Thyroid Nodules: Consensus Statement and Recommendation by Joachim Feldkamp, F. Grünwald, Markus Luster, Kerstin Lorenz, Christian Vorländer, Dagmar Führer

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions

    Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions by Furio Pacini, Yasuhiro Ito, Markus Luster, Fabián Pitoia, Bruce Robinson, Lori J. Wirth

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Fine Needle Aspiration in the Investigation of Thyroid Nodules

    Fine Needle Aspiration in the Investigation of Thyroid Nodules by Joachim Feldkamp, Dagmar Führer, Markus Luster, Thomas J. Musholt, Christine Spitzweg, M. Schott

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review

    rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review by Markus Luster, Francesco Lippi, Barbara Jarząb, Petros Perros, Michael Laßmann, Christoph Reiners, Furio Pacini

    Published 2005
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade

    Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade by Frederik A. Verburg, Glenn Flux, Luca Giovanella, Douglas Van Nostrand, Kristoff Muylle, Markus Luster

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Optimized Peptide Amount and Activity for <sup>90</sup>Y-Labeled DOTATATE Therapy

    Optimized Peptide Amount and Activity for <sup>90</sup>Y-Labeled DOTATATE Therapy by Peter Kletting, Thomas Kull, Christian Maaß, Noeen Malik, Markus Luster, Ambros J. Beer, Gerhard Glatting

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”

    Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray” by Boudewijn Brans, Lisa Bodei, Francesco Giammarile, O. Lindén, Markus Luster, Wim J.G. Oyen, Jan Tennvall

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Indications for the Surgical Management of Benign Goiter in Adults

    Indications for the Surgical Management of Benign Goiter in Adults by Detlef K. Bartsch, Markus Luster, H. J. Buhr, Dietmar Lorenz, Christoph‐Thomas Germer, Peter E. Goretzki

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Targeted therapy in nuclear medicine—current status and future prospects

    Targeted therapy in nuclear medicine—current status and future prospects by Wim J.G. Oyen, Lisa Bodei, Francesco Giammarile, Helmut R. Maëcke, Jan Tennvall, Markus Luster, Boudewijn Brans

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients ≥ 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and Normal in All Other DTC Patients

    Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients ≥ 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and... by Frederik A. Verburg, Uwe Mäder, Karina Tanase, E. Thies, Stefanie Dießl, Andreas K. Buck, Markus Luster, Christoph Reiners

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?

    2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? by Furio Pacini, Dagmar Führer, Rossella Elisei, Daria Handkiewicz-Junak, Sophie Leboulleux, Markus Luster, Martin Schlumberger, Johannes W. A. Smit

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy

    The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy by Scott A. Rivkees, Ernest L. Mazzaferri, Frederik A. Verburg, Christoph Reiners, Markus Luster, Christopher K. Breuer, Catherine Dinauer, Robert Udelsman

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Mutation-based, short-term “neoadjuvant” treatment allows resectability in stage IVB and C anaplastic thyroid cancer

    Mutation-based, short-term “neoadjuvant” treatment allows resectability in stage IVB and C anaplastic thyroid cancer by Elisabeth Maurer, Friederike Eilsberger, Sabine Wächter, Jorge Riera Knorrenschild, Anika Pehl, Katharina Holzer, Andreas Neubauer, Markus Luster, Detlef K. Bartsch

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Potency and Tolerance of Calcitonin Stimulation with High-Dose Calcium<i>Versus</i>Pentagastrin in Normal Adults

    Potency and Tolerance of Calcitonin Stimulation with High-Dose Calcium<i>Versus</i>Pentagastrin in Normal Adults by Pat Doyle, Christian Düren, Kai Nerlich, Frederik A. Verburg, I. Grelle, Hanne Jahn, Martin Faßnacht, Uwe Mäder, Christoph Reiners, Markus Luster

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: